Codex Labs
PrivateLast Round
Corporate Funding
Dec 4, 2023
Total Funding Raised
$24.4M
Company Overview
Codex Labs is a biotechnology company that develops and sells plant-based topical and ingestible products for various skin conditions.
Sector
Consumer & Commerce
Verticals
Fashion & Beauty, D2C Brands, Biotechnology
Business Model
B2C
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Codex Labs Comparables
Compare Codex Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ellis Day Skin Science | 84% | |
| OneSkin | 82% | |
| Mother Science | 80% | |
Codex Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 4, 2023 | ||||
| Series A | Jun 3, 2019 | ||||
| Early Funding | Jul 19, 2018 |
Codex Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sekhmet Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2019
$8M round led by Sekhmet Ventures.
Codex Labs Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Codex Labs's valuation, stock price, and market status.